Literature DB >> 19205914

Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors.

Georgia Melagraki1, Antreas Afantitis, Haralambos Sarimveis, Panayiotis A Koutentis, George Kollias, Olga Igglessi-Markopoulou.   

Abstract

A linear Quantitative Structure-Activity Relationship (QSAR) is developed in this work for modeling and predicting HDAC inhibition by 5-pyridin-2-yl-thiophene-2-hydroxamic acids. In particular, a five-variable model is produced by using the Multiple Linear Regression (MLR) technique and the Elimination Selection-Stepwise Regression Method (ES-SWR) on a database that consists of 58 recently discovered 5-pyridin-2-yl-thiophene-2-hydroxamic acids and 69 descriptors. The physical meaning of the selected descriptors is discussed in detail. The validity of the proposed MLR model is established using the following techniques: cross validation, validation through an external test set and Y-randomization. Furthermore, the domain of applicability which indicates the area of reliable predictions is defined. Based on the produced model, an in silico-screening study explores novel structural patterns and suggests new potent lead compounds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205914     DOI: 10.1007/s11030-009-9115-2

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  40 in total

1.  3D-QSAR studies of indole derivatives as phosphodiesterase IV inhibitors.

Authors:  Asit K Chakraborti; B Gopalakrishnan; M Elizabeth Sobhia; Alpeshkumar Malde
Journal:  Eur J Med Chem       Date:  2003 Nov-Dec       Impact factor: 6.514

2.  Quantitative structure-activity relationship study of histone deacetylase inhibitors.

Authors:  Aihua Xie; Chenzhong Liao; Zhibin Li; Zhiqiang Ning; Weiming Hu; Xianping Lu; Leming Shi; Jiaju Zhou
Journal:  Curr Med Chem Anticancer Agents       Date:  2004-05

3.  A novel QSAR model for predicting induction of apoptosis by 4-aryl-4H-chromenes.

Authors:  Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A Koutentis; John Markopoulos; Olga Igglessi-Markopoulou
Journal:  Bioorg Med Chem       Date:  2006-06-16       Impact factor: 3.641

Review 4.  Regression methods for developing QSAR and QSPR models to predict compounds of specific pharmacodynamic, pharmacokinetic and toxicological properties.

Authors:  C W Yap; H Li; Z L Ji; Y Z Chen
Journal:  Mini Rev Med Chem       Date:  2007-11       Impact factor: 3.862

5.  Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor.

Authors:  Binbin Xia; Weiping Ma; Bo Zheng; Xiaoyun Zhang; Botao Fan
Journal:  Eur J Med Chem       Date:  2007-09-15       Impact factor: 6.514

Review 6.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

7.  Application of genetic algorithm-kernel partial least square as a novel nonlinear feature selection method: activity of carbonic anhydrase II inhibitors.

Authors:  Mehdi Jalali-Heravi; Anahita Kyani
Journal:  Eur J Med Chem       Date:  2007-01-12       Impact factor: 6.514

8.  Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies.

Authors:  Rino Ragno; Silvia Simeoni; Dante Rotili; Antonella Caroli; Giorgia Botta; Gerald Brosch; Silvio Massa; Antonello Mai
Journal:  Eur J Med Chem       Date:  2007-05-27       Impact factor: 6.514

Review 9.  Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.

Authors:  V Santini; A Gozzini; G Ferrari
Journal:  Curr Drug Metab       Date:  2007-05       Impact factor: 3.731

10.  Identification of a series of novel derivatives as potent HCV inhibitors by a ligand-based virtual screening optimized procedure.

Authors:  Georgia Melagraki; Antreas Afantitis; Haralambos Sarimveis; Panayiotis A Koutentis; John Markopoulos; Olga Igglessi-Markopoulou
Journal:  Bioorg Med Chem       Date:  2007-08-25       Impact factor: 3.641

View more
  8 in total

1.  First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines.

Authors:  Isela García; Yagamare Fall; Generosa Gómez; Humberto González-Díaz
Journal:  Mol Divers       Date:  2010-10-08       Impact factor: 2.943

2.  A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs.

Authors:  Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A Koutentis; Olga Igglessi-Markopoulou; George Kollias
Journal:  Mol Divers       Date:  2009-05-30       Impact factor: 2.943

3.  Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays.

Authors:  Zainab Noor; Noreen Afzal; Sajid Rashid
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

4.  QSAR models for CXCR2 receptor antagonists based on the genetic algorithm for data preprocessing prior to application of the PLS linear regression method and design of the new compounds using in silico virtual screening.

Authors:  Tahereh Asadollahi; Shayessteh Dadfarnia; Ali Mohammad Haji Shabani; Jahan B Ghasemi; Maryam Sarkhosh
Journal:  Molecules       Date:  2011-02-25       Impact factor: 4.411

5.  Antimicrobial Isoflavones and Derivatives from Erythrina (Fabaceae): Structure Activity Perspective (Sar & Qsar) on Experimental and Mined Values Against Staphylococcus Aureus.

Authors:  Nicholas J Sadgrove; Tiago B Oliveira; Gugulethu P Khumalo; Sandy F van Vuuren; Ben-Erik van Wyk
Journal:  Antibiotics (Basel)       Date:  2020-04-30

6.  Ligand-based prediction of hERG-mediated cardiotoxicity based on the integration of different machine learning techniques.

Authors:  Pietro Delre; Giovanna J Lavado; Giuseppe Lamanna; Michele Saviano; Alessandra Roncaglioni; Emilio Benfenati; Giuseppe Felice Mangiatordi; Domenico Gadaleta
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

7.  Virtual screening and experimental validation of novel histone deacetylase inhibitors.

Authors:  Yan-Xin Huang; Jian Zhao; Qiu-Hang Song; Li-Hua Zheng; Cong Fan; Ting-Ting Liu; Yong-Li Bao; Lu-Guo Sun; Li-Biao Zhang; Yu-Xin Li
Journal:  BMC Pharmacol Toxicol       Date:  2016-07-21       Impact factor: 2.483

8.  In Silico Screening of IL-1β Production Inhibitors Using Chemometric Tools.

Authors:  Amirhossein Sakhteman; Najmeh Edraki; Bahram Hemmateenejad; Ramin Miri; Alireza Foroumadi; Abbas Shafiee; Mehdi Khoshneviszadeh
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.